Detalhe da pesquisa
1.
Whirling Platelets Away for Transfusion.
Cell
; 174(3): 503-504, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30053423
2.
Mapping genotypes to chromatin accessibility profiles in single cells.
Nature
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720070
3.
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera.
N Engl J Med
; 390(8): 723-735, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381675
4.
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis.
Blood
; 141(20): 2508-2519, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800567
5.
Somatic mutations and cell identity linked by Genotyping of Transcriptomes.
Nature
; 571(7765): 355-360, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31270458
6.
IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms.
Blood
; 140(26): 2805-2817, 2022 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283106
7.
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Blood
; 139(19): 2931-2941, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007321
8.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
9.
Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression.
Int J Mol Sci
; 25(7)2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612873
10.
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis.
Curr Opin Hematol
; 30(2): 45-52, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728649
11.
Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.
Blood
; 137(9): 1145-1153, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33237986
12.
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.
Blood
; 135(19): 1696-1703, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107559
13.
JAK inhibitors in the treatment of myelofibrosis.
Clin Adv Hematol Oncol
; 20(7): 456-467, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802878
14.
Oral idasanutlin in patients with polycythemia vera.
Blood
; 134(6): 525-533, 2019 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31167802
15.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Blood
; 134(18): 1498-1509, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515250
16.
The possible role of mutated endothelial cells in myeloproliferative neoplasms.
Haematologica
; 106(11): 2813-2823, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320782
17.
Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenografts.
Cytotherapy
; 23(9): 841-851, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023194
18.
Emerging drugs for the treatment of myelofibrosis: phase II & III clinical trials.
Expert Opin Emerg Drugs
; 26(4): 351-362, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875179
19.
Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia.
Pediatr Blood Cancer
; 68(3): e28888, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33381905
20.
Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms.
Acta Haematol
; 144(1): 48-57, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160610